Harbor Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Harbor Advisory's XBI Position: Q2 2025 in Review
Harbor Advisory sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 29,384 shares — an estimated $2.38M sold.
Harbor Advisory first reported a position in XBI in Q2 2021 and held it in 16 quarters. The position peaked at $3.17M in Q1 2024. 628 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Harbor Advisory reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Harbor Advisory sold 29,384 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $2.38M.
- Harbor Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 16 quarters.
- Harbor Advisory's State Street SPDR S&P Biotech ETF position peaked at $3.17M in Q1 2024.
- 628 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Harbor Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.